Literature DB >> 16209160

Niacinamide-containing facial moisturizer improves skin barrier and benefits subjects with rosacea.

Zoe Diana Draelos1, Keith Ertel, Cindy Berge.   

Abstract

A growing body of literature suggests that some moisturizers can improve stratum corneum barrier function, as well as ameliorate dry skin. The clinical signs and symptoms of rosacea, which include increased facial skin dryness and sensitivity, suggest a possible role for such moisturizers as an adjuvant in the management of this condition. This randomized, investigator-blind, controlled observational study (N = 50) was designed to assess whether a niacinamide-containing facial moisturizer would improve the stratum corneum barrier and thus provide a clinical benefit to subjects with rosacea. Subjects with rosacea applied the test moisturizer to their face and to one forearm twice daily for 4 weeks. The other forearm remained untreated as a control. Barrier function on the forearms was assessed instrumentally and using a dimethyl sulfoxide (DMSO) chemical probe. Stratum corneum hydration also was measured instrumentally. The dermatologist investigator evaluated each subject's rosacea condition over the course of the study, and subjects self-assessed their facial skin condition at study end. Instruments provided objective measures of stratum corneum barrier function and hydration on the face.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16209160

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  12 in total

1.  A Guide to the Ingredients and Potential Benefits of Over-the-Counter Cleansers and Moisturizers for Rosacea Patients.

Authors:  Jacquelyn Levin; Richard Miller
Journal:  J Clin Aesthet Dermatol       Date:  2011-08

Review 2.  Interventions for rosacea.

Authors:  Esther J van Zuuren; Zbys Fedorowicz; Ben Carter; Mireille M D van der Linden; Lyn Charland
Journal:  Cochrane Database Syst Rev       Date:  2015-04-28

3.  [Urea plus ceramides and vitamins: improving the efficacy of a topical urea preparation by addition of ceramides and vitamins].

Authors:  S Grether-Beck; K Mühlberg; H Brenden; J Krutmann
Journal:  Hautarzt       Date:  2008-09       Impact factor: 0.751

4.  A randomized, controlled comparative study of the wrinkle reduction benefits of a cosmetic niacinamide/peptide/retinyl propionate product regimen vs. a prescription 0.02% tretinoin product regimen.

Authors:  J J J Fu; G G Hillebrand; P Raleigh; J Li; M J Marmor; V Bertucci; P E Grimes; S H Mandy; M I Perez; S H Weinkle; J R Kaczvinsky
Journal:  Br J Dermatol       Date:  2010-03       Impact factor: 9.302

Review 5.  Treatment of Actinic Purpura.

Authors:  Roger I Ceilley
Journal:  J Clin Aesthet Dermatol       Date:  2017-06-01

6.  Preparation and pharmaceutical evaluation of nicotinamide stick for eradication of Staphylococcus epidermidis.

Authors:  Mohammad Ali Shahtalebi; Rahim Bahrinajafi; Sima Nahavandi
Journal:  J Res Med Sci       Date:  2014-07       Impact factor: 1.852

7.  Evaluation of a novel very high sun-protection-factor moisturizer in adults with rosacea-prone sensitive skin.

Authors:  Mathieu Grivet-Seyve; Francine Santoro; Nadège Lachmann
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-06-10

8.  A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea-prone skin.

Authors:  Hilary Baldwin; Francine Santoro; Nadege Lachmann; Sandrine Teissedre
Journal:  J Cosmet Dermatol       Date:  2019-02-25       Impact factor: 2.696

9.  An Open-Label, Intra-Individual Study to Evaluate a Regimen of Three Cosmetic Products Combined with Medical Treatment of Rosacea: Cutaneous Tolerability and Effect on Hydration.

Authors:  Francine Santoro; Nadège Lachmann
Journal:  Dermatol Ther (Heidelb)       Date:  2019-10-17

10.  Effects of skin care habits on the development of rosacea: A multi-center retrospective case-control survey in Chinese population.

Authors:  Ying-Xue Huang; Ji Li; Zhi-Xiang Zhao; Bo-Lan Zheng; Yu-Xuan Deng; Wei Shi; Martin Steinhoff; Hong-Fu Xie
Journal:  PLoS One       Date:  2020-04-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.